Tag Archives: more

#435583 Soft Self-Healing Materials for Robots ...

If there’s one thing we know about robots, it’s that they break. They break, like, literally all the time. The software breaks. The hardware breaks. The bits that you think could never, ever, ever possibly break end up breaking just when you need them not to break the most, and then you have to try to explain what happened to your advisor who’s been standing there watching your robot fail and then stay up all night fixing the thing that seriously was not supposed to break.

While most of this is just a fundamental characteristic of robots that can’t be helped, the European Commission is funding a project called SHERO (Self HEaling soft RObotics) to try and solve at least some of those physical robot breaking problems through the use of structural materials that can autonomously heal themselves over and over again.

SHERO is a three year, €3 million collaboration between Vrije Universiteit Brussel, University of Cambridge, École Supérieure de Physique et de Chimie Industrielles de la ville de Paris (ESPCI-Paris), and Swiss Federal Laboratories for Materials Science and Technology (Empa). As the name SHERO suggests, the goal of the project is to develop soft materials that can completely recover from the kinds of damage that robots are likely to suffer in day to day operations, as well as the occasional more extreme accident.

Most materials, especially soft materials, are fixable somehow, whether it’s with super glue or duct tape. But fixing things involves a human first identifying when they’re broken, and then performing a potentially skill, labor, time, and money intensive task. SHERO’s soft materials will, eventually, make this entire process autonomous, allowing robots to self-identify damage and initiate healing on their own.

Photos: SHERO Project

The damaged robot finger [top] can operate normally after healing itself.

How the self-healing material works
What these self-healing materials can do is really pretty amazing. The researchers are actually developing two different types—the first one heals itself when there’s an application of heat, either internally or externally, which gives some control over when and how the healing process starts. For example, if the robot is handling stuff that’s dirty, you’d want to get it cleaned up before healing it so that dirt doesn’t become embedded in the material. This could mean that the robot either takes itself to a heating station, or it could activate some kind of embedded heating mechanism to be more self-sufficient.

The second kind of self-healing material is autonomous, in that it will heal itself at room temperature without any additional input, and is probably more suitable for relatively minor scrapes and cracks. Here are some numbers about how well the healing works:

Autonomous self-healing polymers do not require heat. They can heal damage at room temperature. Developing soft robotic systems from autonomous self-healing polymers excludes the need of additional heating devices… The healing however takes some time. The healing efficiency after 3 days, 7 days and 14 days is respectively 62 percent, 91 percent and 97 percent.

This material was used to develop a healable soft pneumatic hand. Relevant large cuts can be healed entirely without the need of external heat stimulus. Depending on the size of the damage and even more on the location of damage, the healing takes only seconds or up to a week. Damage on locations on the actuator that are subjected to very small stresses during actuation was healed instantaneously. Larger damages, like cutting the actuator completely in half, took 7 days to heal. But even this severe damage could be healed completely without the need of any external stimulus.

Applications of self-healing robots
Both of these materials can be mixed together, and their mechanical properties can be customized so that the structure that they’re a part of can be tuned to move in different ways. The researchers also plan on introducing flexible conductive sensors into the material, which will help sense damage as well as providing position feedback for control systems. A lot of development will happen over the next few years, and for more details, we spoke with Bram Vanderborght at Vrije Universiteit in Brussels.

IEEE Spectrum: How easy or difficult or expensive is it to produce these materials? Will they add significant cost to robotic grippers?

Bram Vanderborght: They are definitely more expensive materials, but it’s also a matter of size of production. At the moment, we’ve made a few kilograms of the material (enough to make several demonstrators), and the price already dropped significantly from when we ordered 100 grams of the material in the first phase of the project. So probably the cost of the gripper will be higher [than a regular gripper], but you won’t need to replace the gripper as often as other grippers that need to be replaced due to wear, so it can be an advantage.

Moreover due to the method of 3D printing the material, the surface is smoother and airtight (so no post-processing is required to make it airtight). Also, the smooth surface is better to avoid contamination for food handling, for example.

In commercial or industrial applications, gradual fatigue seems to be a more common issue than more abrupt trauma like cuts. How well does the self-healing work to improve durability over long periods of time?

We did not test for gradual fatigue over very long times. But both macroscopic and microscopic damage can be healed. So hopefully it can provide an answer here as well.

Image: SHERO Project

After developing a self-healing robot gripper, the researchers plan to use similar materials to build parts that can be used as the skeleton of robots, allowing them to repair themselves on a regular basis.

How much does the self-healing capability restrict the material properties? What are the limits for softness or hardness or smoothness or other characteristics of the material?

Typically the mechanical properties of networked polymers are much better than thermoplastics. Our material is a networked polymer but in which the crosslinks are reversible. We can change quite a lot of parameters in the design of the materials. So we can develop very stiff (fracture strain at 1.24 percent) and very elastic materials (fracture strain at 450 percent). The big advantage that our material has is we can mix it to have intermediate properties. Moreover, at the interface of the materials with different mechanical properties, we have the same chemical bonds, so the interface is perfect. While other materials, they may need to glue it, which gives local stresses and a weak spot.

When the material heals itself, is it less structurally sound in that spot? Can it heal damage that happens to the same spot over and over again?

In theory we can heal it an infinite amount of times. When the wound is not perfectly aligned, of course in that spot it will become weaker. Also too high temperatures lead to irreversible bonds, and impurities lead to weak spots.

Besides grippers and skins, what other potential robotics applications would this technology be useful for?

Most of self healing materials available now are used for coatings. What we are developing are structural components, therefore the mechanical properties of the material need to be good for such applications. So maybe part of the skeleton of the robot can be developed with such materials to make it lighter, since can be designed for regular repair. And for exceptional loads, it breaks and can be repaired like our human body.

[ SHERO Project ] Continue reading

Posted in Human Robots

#435579 RoMeLa’s Newest Robot Is a ...

A few years ago, we wrote about NABiRoS, a bipedal robot from Dennis Hong’s Robotics & Mechanisms Laboratory (RoMeLa) at UCLA. Unlike pretty much any other biped we’d ever seen, NABiRoS had a unique kinematic configuration that had it using its two legs to walk sideways, which offered some surprising advantages.

As it turns out, bipeds aren’t the only robots that can potentially benefit from a bit of a kinematic rethink. RoMeLa has redesigned quadrupedal robots too—rather than model them after a quadrupedal animal like a dog or a horse, RoMeLa’s ALPHRED robots use four legs arranged symmetrically around the body of the robot, allowing it to walk, run, hop, and jump, as well as manipulate and carry objects, karate chop through boards, and even roller skate on its butt. This robot can do it all.

Impressive, right? This is ALPHRED 2, and its predecessor, the original ALPHRED, was introduced at IROS 2018. Both ALPHREDs are axisymmetric about the vertical axis, meaning that they don’t have a front or a back and are perfectly happy to walk in any direction you like. Traditional quadrupeds like Spot or Laikago can also move sideways and backwards, but their leg arrangement makes them more efficient at moving in one particular direction, and also results in some curious compromises like a preference for going down stairs backwards. ANYmal is a bit more flexible in that it can reverse its knees, but it’s still got that traditional quadrupedal two-by-two configuration.

ALPHRED 2’s four symmetrical limbs can be used for a whole bunch of stuff. It can do quadrupedal walking and running, and it’s able to reach stable speeds of up to 1.5 m/s. If you want bipedal walking, it can do that NABiRoS-style, although it’s still a bit fragile at the moment. Using two legs for walking leaves two legs free, and those legs can turn into arms. A tripedal compromise configuration, with three legs and one arm, is more stable and allows the robot to do things like push buttons, open doors, and destroy property. And thanks to passive wheels under its body, ALPHRED 2 can use its limbs to quickly and efficiently skate around:

The impressive performance of the robot comes courtesy of a custom actuator that RoMeLa designed specifically for dynamic legged locomotion. They call it BEAR, or Back-Drivable Electromechanical Actuator for Robots. These are optionally liquid-cooled motors capable of proprioceptive sensing, consisting of a DC motor, a single stage 10:1 planetary gearbox, and channels through the back of the housing that coolant can be pumped through. The actuators have a peak torque of 32 Nm, and a continuous torque of about 8 Nm with passive air cooling. With liquid cooling, the continuous torque jumps to about 21 Nm. And in the videos above, ALPHRED 2 isn’t even running the liquid cooling system, suggesting that it’s capable of much higher sustained performance.

Photo: RoMeLa

Using two legs for walking leaves two legs free, and those legs can turn into arms.

RoMeLa has produced a bunch of very creative robots, and we appreciate that they also seem to produce a bunch of very creative demos showing why their unusual approaches are in fact (at least in some specific cases) somewhat practical. With the recent interest in highly dynamic robots that can be reliably useful in environments infested with humans, we can’t wait to see what kinds of exciting tricks the next (presumably liquid-cooled) version will be able to do.

[ RoMeLa ] Continue reading

Posted in Human Robots

#435575 How an AI Startup Designed a Drug ...

Discovering a new drug can take decades, billions of dollars, and untold man hours from some of the smartest people on the planet. Now a startup says it’s taken a significant step towards speeding the process up using AI.

The typical drug discovery process involves carrying out physical tests on enormous libraries of molecules, and even with the help of robotics it’s an arduous process. The idea of sidestepping this by using computers to virtually screen for promising candidates has been around for decades. But progress has been underwhelming, and it’s still not a major part of commercial pipelines.

Recent advances in deep learning, however, have reignited hopes for the field, and major pharma companies have started tying up with AI-powered drug discovery startups. And now Insilico Medicine has used AI to design a molecule that effectively targets a protein involved in fibrosis—the formation of excess fibrous tissue—in mice in just 46 days.

The platform the company has developed combines two of the hottest sub-fields of AI: the generative adversarial networks, or GANs, which power deepfakes, and reinforcement learning, which is at the heart of the most impressive game-playing AI advances of recent years.

In a paper in Nature Biotechnology, the company’s researchers describe how they trained their model on all the molecules already known to target this protein as well as many other active molecules from various datasets. The model was then used to generate 30,000 candidate molecules.

Unlike most previous efforts, they went a step further and selected the most promising molecules for testing in the lab. The 30,000 candidates were whittled down to just 6 using more conventional drug discovery approaches and were then synthesized in the lab. They were put through increasingly stringent tests, but the leading candidate was found to be effective at targeting the desired protein and behaved as one would hope a drug would.

The authors are clear that the results are just a proof-of-concept, which company CEO Alex Zhavoronkov told Wired stemmed from a challenge set by a pharma partner to design a drug as quickly as possible. But they say they were able to carry out the process faster than traditional methods for a fraction of the cost.

There are some caveats. For a start, the protein being targeted is already very well known and multiple effective drugs exist for it. That gave the company a wealth of data to train their model on, something that isn’t the case for many of the diseases where we urgently need new drugs.

The company’s platform also only targets the very initial stages of the drug discovery process. The authors concede in their paper that the molecules would still take considerable optimization in the lab before they’d be true contenders for clinical trials.

“And that is where you will start to begin to commence to spend the vast piles of money that you will eventually go through in trying to get a drug to market,” writes Derek Lowe in his blog In The Pipeline. The part of the discovery process that the platform tackles represents a tiny fraction of the total cost of drug development, he says.

Nonetheless, the research is a definite advance for virtual screening technology and an important marker of the potential of AI for designing new medicines. Zhavoronkov also told Wired that this research was done more than a year ago, and they’ve since adapted the platform to go after harder drug targets with less data.

And with big pharma companies desperate to slash their ballooning development costs and find treatments for a host of intractable diseases, they can use all the help they can get.

Image Credit: freestocks.org / Unsplash Continue reading

Posted in Human Robots

#435567 Video Friday: Misty Robotics Begins ...

Your weekly selection of awesome robot videos Continue reading

Posted in Human Robots

#435547 Blue Ocean Robotics Acquires Beam ...

Beam now belongs to a Danish robot venture factory Continue reading

Posted in Human Robots